We are reader-supported. When you buy through links on our site, we may earn affiliate commission.
As the world is still recovering from COVID-19, health experts warn that superbugs are an equally dangerous, quietly escalating threat. Unlike viral pandemics that emerge suddenly, the superbug crisis has been building slowly, driven by a complex web of human activities. Interestingly, superbugs don’t originate from hospitals. They are a result of environmental causes.
Superbugs are bacteria that have evolved to resist even our most powerful antibiotics, and they kill an estimated 1.2 million people each year. When individuals think about antibiotic resistance, they typically imagine overuse in human medicine. Common examples include doctors prescribing antibiotics for viral infections, even though they don’t affect viruses, and patients forgetting to finish their antibiotic courses. While these factors contribute to the superbugs problem, they are only part of it.
The true cause of the spread of superbugs is happening outside clinics and hospitals because we don’t just use antibiotics for human illnesses. Primary contributors include agriculture, the pharmaceutical industry and even domestic households, reflecting how the pathway from environmental resistance to human disease is more prevalent than many would expect.
The environmental link that makes superbugs a pandemic-level threat is a vast interconnected system that continuously generates and spreads resistance. For example, a resistant bacterial strain that emerged in a pig farm in South Asia could potentially become a human pathogen in Europe.
Agriculture is one of the largest consumers of antibiotics worldwide. In many countries, livestock farmers use antibiotics for more than just treating sick animals. They routinely administer it to livestock, such as chickens and pigs, to boost growth and prevent disease in crowded conditions.
The antibiotics pass through animal digestive systems, most of the time largely intact, and end up in manure that becomes fertilizer for fields. From there, both resistant bacteria and antibiotic residues leach into groundwater or wash into rivers and streams. Food is also another major transmission route. For example, produce irrigated with contaminated water can harbor resistant bacteria.
The pharmaceutical industry adds another layer to the superbug crisis. A significant number of drug manufacturing facilities discharge wastewater containing active pharmaceutical ingredients directly into local waterways. Even in cases where only household sources are included, around 3.7 million miles of rivers worldwide have antibiotic concentrations exceeding safe limits. These conditions become the perfect ground for bacteria to develop resistance.
Personal antibiotic use contributes to the rise of superbugs. Every time someone takes antibiotics, a portion of the drug will pass through the body and enter the sewage system. Because municipal wastewater treatment plants aren’t capable of removing these compounds, they flow back into the environment.
As the superbug crisis operates largely outside the awareness and control of most people, there’s often a lack of urgency to act on it. Unlike COVID-19, which disrupted the world but eventually became manageable, antibiotic resistance might not offer the same hope for vaccines or herd immunity.
Once antibiotic resistance becomes widespread, there is no easy way back. As bacteria evolve faster than experts can develop new drugs, healthcare could struggle to keep up. The implications, while not immediately apparent, are staggering:
Solutions exist at every level, from individual choices to global policy reforms. Steps to resolve environmental links should be prioritized.
Reduce routine antibiotic use through stewardship programs, better hygiene, vaccination and disease-resistant breeding. Strong regulations, such as banning growth promotion and prioritizing veterinary oversight, are key to scaling these efforts globally.
Enforcing stricter environmental standards in pharmaceutical production, along with market incentives and transparency, can further push companies toward cleaner and more accountable practices.
Infrastructure, such as advanced wastewater treatment technologies, can remove antibiotics and resistant bacteria. However, this requires significant investment. Simpler measures, such as managing agricultural runoff and properly treating manure, can also help reduce environmental contamination.
Consumers can influence change by choosing responsibly produced food, using antibiotics appropriately and supporting regulations. Proper drug disposal and reducing food waste also minimize the spread of antibiotic residues into the environment.
Addressing antibiotic resistance requires coordinated effort. The World Health Organization proposes the One Health approach, which recognizes the inextricable interconnection between environmental, animal and human health. It calls for coordinated action across sectors such as healthcare, agriculture and environmental management to tackle health issues.
This approach is particularly crucial for addressing challenges such as antimicrobial resistance. It provides the community with a framework to address the crisis before it progresses to a pandemic-level threat. The One Health approach outlines several core priorities for tackling antimicrobial resistance at a global level:
The superbug crisis is unfolding slowly but surely. Whether or not it becomes the next pandemic, it is a profound threat with a strong environmental link that requires a coordinated response. Acting now is essential to prevent a future in which common infections become deadly.
